Ignite Creation Date:
2024-05-06 @ 2:52 PM
Last Modification Date:
2024-10-26 @ 1:38 PM
Study NCT ID:
NCT04442178
Status:
TERMINATED
Last Update Posted:
2022-04-08
First Post:
2020-06-19
Brief Title:
InterLeukin-7 to Improve Clinical Outcomes in Lymphopenic pAtients With COVID-19 Infection ILIAD-7-US-I
Sponsor:
Revimmune
Organization:
Revimmune
Organization Data
Organization:
Revimmune
Class:
INDUSTRY
Study ID:
ILIAD-7 COVID US INFECTIOUS
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Revimmune
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Amarex Clinical Research | OTHER |
| Washington University School of Medicine | OTHER |